Literature DB >> 6970053

Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells.

L Boumsell, A Bernard, E L Reinherz, L M Nadler, J Ritz, H Coppin, Y Richard, L Dubertret, F Valensi, L Degos, J Lemerle, G Flandrin, J Dausset, S F Schlossman.   

Abstract

Tumor cells from eight adult patients with T-cell chronic malignancies were investigated with a series of monoclonal antibodies recognizing T-cell differentiation antigens. This series allowed definition of discrete subpopulations of mature T cells with functional specialization. All six patients with Sézary syndrome and one patient with T-chronic lymphocytic leukemia had cells with the same phenotype as normal helper/inducer T cells, whereas the other patient with T-chronic lymphocytic leukemia had cell with the same phenotype as normal cytotoxic/suppressor T cells. Some clinical manifestations observed in these patients may reflect retention of functional activities by their malignant cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970053

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  MHC class I and class I-like gene product expression by malignant T cells: relationships between CD1a, HLA-ABC and beta 2-microglobulin.

Authors:  R A Jones; C S Scott; F E Katz; J A Child
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

2.  Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review.

Authors:  Alan A Moazzam; Jan Drappatz; Ryan Y Kim; Santosh Kesari
Journal:  J Neurooncol       Date:  2011-07-17       Impact factor: 4.130

Review 3.  A lymphoproliferative disorder of the large granular lymphocytes with natural killer activity.

Authors:  M Ferrarini; S Romagnani; E Montesoro; A Zicca; G F Del Prete; A Nocera; E Maggi; A Leprini; C E Grossi
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

4.  Monoclonal antibodies against differentiation antigens of lymphopoiesis.

Authors:  E Thiel
Journal:  Blut       Date:  1983-11

5.  Phenotypic heterogeneity of leukemic Sézary cells.

Authors:  A C Feller; A Ziegler; W Sterry; M Goos; M R Parwaresch
Journal:  Blut       Date:  1983-12

6.  Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab.

Authors:  Naoko Watanabe; Takayuki Takahashi; Naoshi Sugimoto; Yasuhiro Tanaka; Masayuki Kurata; Akiko Matsushita; Akinori Maeda; Kenichi Nagai; Kohji Nasu
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

7.  Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases.

Authors:  D M Knowles; J P Halper
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

8.  Interleukin-7 is a growth factor for Sézary lymphoma cells.

Authors:  A Dalloul; L Laroche; M Bagot; M D Mossalayi; C Fourcade; D J Thacker; D E Hogge; H Merle-Béral; P Debré; C Schmitt
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Pleomorphic T-cell leukaemia in a Caucasian adult: clinical phenotypic and functional characteristics.

Authors:  C J Hawkey; A C Campbell; G A Bird; D I Gozzard; R A Robins; P J Toghill
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

10.  T cells in patients with chronic T gamma lymphocytosis: morphology, cytochemistry, ultrastructure and immunological characteristics.

Authors:  J W Smit; N R Blom; M J van Luyn; F Miedema; C J Melief; M R Halie
Journal:  Blut       Date:  1985-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.